229.76USD-0.48%Mkt Cap: 4.61B USDP/E: 29.94Last update: 2026-06-01
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap4.61B USD
Enterprise Value4.32B USD
Revenue (TTM)274.48M USD
Gross Profit253.54M USD
Net Income (TTM)124.45M USD
Revenue/Share14.07 USD
Last Price229.76 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees47
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS53220K5048
Valuation
P/E (Trailing)29.94
P/E (Forward)20.50
PEG1.53
EV/EBITDA32.14
EV/Revenue15.74
P/S16.94
P/B4.66
EPS (TTM)7.68
EPS (Forward)11.32
52W Range
98.8988% of range247.38
52W High247.38 USD
52W Low98.89 USD
Profitability
Gross Margin94.57%
Oper. Margin33.58%
EBITDA Margin48.98%
Profit Margin46.42%
ROE12.23%
ROA7.97%
Growth
Revenue Growth14.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF49.36M USD
CapEx (TTM)11.31M USD
FCF Margin51.77%
FCF Yield3.08%
Net Debt-327.43M USD
Net Debt/EBITDA-2.44
Balance Sheet
Debt/Equity0.44
Current Ratio21.28
Quick Ratio20.81
Book Value/Sh49.79 USD
Cash/Share38.89 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateJul 2, 2010
Pay Date—
Splits
Last Split1603:1000
Split DateNov 2, 2022
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)272.10 USD
Target Range220.00 USD – 330.00 USD
# Analysts10
Ownership
Shares Out.20.04M
Float19.57M
Insiders2.39%
Institutions106.34%
Short Interest
Short Ratio7.2d
Short % Float9.00%
Short % Out.7.51%
Shares Short1.51M
Short (prev mo.)1.41M
Technical
SMA 50217.76 (+5.5%)
SMA 200194.74 (+18.0%)
Beta1.07
S&P 52W Chg27.94%
Avg Vol (30d)196.20K
Avg Vol (10d)194.23K
Technical Indicators
RSI (14)56.2
MACD2.9886
MACD Signal1.6072
MACD Hist.+1.3814
BB Upper241.18 USD
BB Middle223.39 USD
BB Lower205.60 USD
BB Width15.93%
ATR (14)8.871 USD
Vol Ratio (20d)0.33x